NEW YORK – An organoid-based test may be able to identify which drugs cancer patients are likely to benefit from, according to an analysis presented during the second virtual session of the American Association for Cancer Research's annual meeting.
NEW YORK – An organoid-based test may be able to identify which drugs cancer patients are likely to benefit from, according to an analysis presented during the second virtual session of the American Association for Cancer Research's annual meeting.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.